Conference Coverage
Conference Coverage
Growing proportion of cardiac arrests in U.S. considered opioid related
Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.
Conference Coverage
STOP-DAPT 2 ACS: 1 month of DAPT proves inadequate for patients with recent ACS
Findings from a Japanese trial show 1 month of dual antiplatelet therapy and 11 months of clopidogrel monotherapy is inferior to 12 months of DAPT...
Conference Coverage
New valvular heart disease guidelines change several repair indications
The new set of ESC/EACTS guidelines for heart valve disease offer more than 45 revised or new recommendations.
Conference Coverage
Tranexamic acid fails to prevent ICH growth: TRAIGE trial results
“Larger studies with more specified population are needed to further assess safety and efficacy of tranexamic acid in patients with ICH.”
Conference Coverage
New European guidelines on CVD prevention
A chief goal of the guideline task force was to create a single CVD prevention guideline for everyone.
Conference Coverage
Two swings, two misses with colchicine, Vascepa in COVID-19
The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.
Conference Coverage
EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEF
The primary report from EMPEROR-Preserved on using empagliflozin to treat patients with HFpEF arrived with four other analyses published in its...
Conference Coverage
ACST-2: Carotid stenting, surgery on par in asymptomatic patients
Periprocedural and 5-year outcomes were generally similar, but not all virtual attendees were convinced that either intervention is necessary in...
Conference Coverage
Angiography can wait for cardiac arrest without ST-elevation
Results of the TOMAHAWK trial show that immediate transfer for angiography after out-of-hospital arrest without ST-segment elevation provided no...
Conference Coverage
Although inconclusive, CV safety study of cancer therapy attracts attention
Even though PRONOUNCE, a trial comparing prostate cancer drugs for cardiovascular safety couldn’t reach a conclusion, it may prove to be a model...
Conference Coverage
LOOP trial undercuts value of long-term continuous ECG screening for AFib
It may be that short bouts of AFib on long-term continuous monitoring aren’t worth seeking out just so anticoagulation can start, even in elderly...